Hot penny stocks... don't get burned
   

Profile for Keryx Biopharmaceuticals, Inc (KERX)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
Profile for Keryx Biopharmaceuticals Inc.  (KERX) 
$ 0.22      -0.01 (-4.35%) Volume: 188.18 k 4:00 PM EDT Oct 10, 2008
Business Description:
A biopharmaceutical company focused on the acquisition and development of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.
Address:    750 Lexington Avenue, New York, NY 10022
Telephone:   
(212) 531-5965
 
Website:   
www.keryx.com
Facsimile:   
(212) 531-5961
Email:   
IR@keryx.com
Details
CEO:   
Michael S. Weiss, J.D.
Employees:   
50
Market Cap:   
9.92 m
Issue Type:   
Common Stock
Auditor:    KPMG LLP
Last Audit:    Unqualified
Indices:    Drug Manufacturers - Major
Industry Classifications
Sector:   
Healthcare
CIK:   
0001114220
Industry:    Drugs
NAICS:    Pharmaceutical Preparation Manufacturing (325412)
QM ID:    Drug Manufacturers - Major (510)
SIC:    Pharmaceutical Preparations (2834)
Profitability
Management Effectiveness
Gross Margin:   
 
Return on Equity:   
 
EBIT Margin:   
 
Return on Capital:   
-1761.90
Profit Margin:   
 
Return on Assets:   
-231.30
Share Statistics
Outstanding:   
45.08 m
Float:   
42.2 m
Short Interest:   
1.6 m (as of 9/25/08)
Short Int Ratio:   
8.50
% of Float:   
3.60%
Non-Corp. Insider Hold'gs:   
1.80% (as of 8/1/08)
Bought Prev 3 Mo:   
430.0 k
Sold Prev 3 Mo:   
0
Institution Hold'gs:   
42.30% (as of 9/1/08)
Total Held:   
19.07 m
Institutions:   
73
Bought Prev Mo:   
1.76 m
Sold Prev Mo:   
6.89 m

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, profiles by Hemscott.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for KERX stock. Download KERX report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download KERX report
  
Example preview: Research report for Keryx Biopharmaceuticals, Inc (KERX) Research report for Keryx Biopharmaceuticals, Inc (KERX) Research report for Keryx Biopharmaceuticals, Inc (KERX) Research report for Keryx Biopharmaceuticals, Inc (KERX)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Keryx Biopharmaceuticals, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.